PL2874611T3 - Dojelitowa farmaceutyczna postać o przedłużonym uwalnianiu - Google Patents
Dojelitowa farmaceutyczna postać o przedłużonym uwalnianiuInfo
- Publication number
- PL2874611T3 PL2874611T3 PL13739677T PL13739677T PL2874611T3 PL 2874611 T3 PL2874611 T3 PL 2874611T3 PL 13739677 T PL13739677 T PL 13739677T PL 13739677 T PL13739677 T PL 13739677T PL 2874611 T3 PL2874611 T3 PL 2874611T3
- Authority
- PL
- Poland
- Prior art keywords
- gastro
- delayed release
- release pharmaceutical
- pharmaceutical form
- resistant delayed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001264A ITMI20121264A1 (it) | 2012-07-19 | 2012-07-19 | Forma farmaceutica gastro-resistente a rilascio ritardato |
| EP13739677.6A EP2874611B1 (en) | 2012-07-19 | 2013-07-18 | Gastro-resistant delayed release pharmaceutical form |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2874611T3 true PL2874611T3 (pl) | 2017-07-31 |
Family
ID=46939787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13739677T PL2874611T3 (pl) | 2012-07-19 | 2013-07-18 | Dojelitowa farmaceutyczna postać o przedłużonym uwalnianiu |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2874611B1 (pl) |
| DK (1) | DK2874611T3 (pl) |
| ES (1) | ES2606352T3 (pl) |
| HR (1) | HRP20161628T1 (pl) |
| HU (1) | HUE032412T2 (pl) |
| IT (1) | ITMI20121264A1 (pl) |
| LT (1) | LT2874611T (pl) |
| PL (1) | PL2874611T3 (pl) |
| PT (1) | PT2874611T (pl) |
| RS (1) | RS55373B1 (pl) |
| SI (1) | SI2874611T1 (pl) |
| WO (1) | WO2014013008A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700048797A1 (it) * | 2017-05-05 | 2018-11-05 | Neilos S R L | Sistema di rilascio controllato di ingredienti attivi a base di materiali polimerici e suo impiego in campo nutraceutico. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW224049B (pl) * | 1991-12-31 | 1994-05-21 | Sunkyong Ind Ltd | |
| FI20085369A0 (fi) * | 2008-04-25 | 2008-04-25 | Kuopion Yliopisto | Gastroresistentti siklosporiiniformulaatio |
-
2012
- 2012-07-19 IT IT001264A patent/ITMI20121264A1/it unknown
-
2013
- 2013-07-18 EP EP13739677.6A patent/EP2874611B1/en active Active
- 2013-07-18 RS RS20161067A patent/RS55373B1/sr unknown
- 2013-07-18 PL PL13739677T patent/PL2874611T3/pl unknown
- 2013-07-18 PT PT137396776T patent/PT2874611T/pt unknown
- 2013-07-18 HU HUE13739677A patent/HUE032412T2/en unknown
- 2013-07-18 HR HRP20161628TT patent/HRP20161628T1/hr unknown
- 2013-07-18 DK DK13739677.6T patent/DK2874611T3/da active
- 2013-07-18 SI SI201330417A patent/SI2874611T1/sl unknown
- 2013-07-18 WO PCT/EP2013/065169 patent/WO2014013008A1/en not_active Ceased
- 2013-07-18 LT LTEP13739677.6T patent/LT2874611T/lt unknown
- 2013-07-18 ES ES13739677.6T patent/ES2606352T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20161628T1 (hr) | 2017-01-13 |
| PT2874611T (pt) | 2016-12-20 |
| HUE032412T2 (en) | 2017-09-28 |
| RS55373B1 (sr) | 2017-03-31 |
| EP2874611B1 (en) | 2016-09-14 |
| LT2874611T (lt) | 2016-12-12 |
| DK2874611T3 (da) | 2017-01-02 |
| ITMI20121264A1 (it) | 2014-01-20 |
| SI2874611T1 (sl) | 2017-04-26 |
| ES2606352T3 (es) | 2017-03-23 |
| WO2014013008A1 (en) | 2014-01-23 |
| EP2874611A1 (en) | 2015-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201406799XA (en) | A delayed release drug formulation | |
| ZA201501930B (en) | Pharmaceutical composition | |
| EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
| ZA201502685B (en) | Capsules | |
| AP3681A (en) | Modified release formulations for oprozomib | |
| GB2502402B (en) | Controlled drug release | |
| HUE037618T2 (hu) | Gyógyszerészeti kombinációk | |
| ZA201407675B (en) | A delayed release drug formulation | |
| ZA201502987B (en) | Pharmaceutical composition | |
| PL2874611T3 (pl) | Dojelitowa farmaceutyczna postać o przedłużonym uwalnianiu | |
| GB201205247D0 (en) | Quadro | |
| GB201220749D0 (en) | Capsules | |
| ZA201400751B (en) | Pharmaceutical composition | |
| GB201119796D0 (en) | Pharmaceutical comopounds |